BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17823927)

  • 1. WWOX hypomorphic mice display a higher incidence of B-cell lymphomas and develop testicular atrophy.
    Ludes-Meyers JH; Kil H; Nuñez MI; Conti CJ; Parker-Thornburg J; Bedford MT; Aldaz CM
    Genes Chromosomes Cancer; 2007 Dec; 46(12):1129-36. PubMed ID: 17823927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted deletion of Wwox reveals a tumor suppressor function.
    Aqeilan RI; Trapasso F; Hussain S; Costinean S; Marshall D; Pekarsky Y; Hagan JP; Zanesi N; Kaou M; Stein GS; Lian JB; Croce CM
    Proc Natl Acad Sci U S A; 2007 Mar; 104(10):3949-54. PubMed ID: 17360458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WWOX: a fragile tumor suppressor.
    Schrock MS; Huebner K
    Exp Biol Med (Maywood); 2015 Mar; 240(3):296-304. PubMed ID: 25538133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WWOX tumor suppressor gene.
    Yang J; Zhang W
    Histol Histopathol; 2008 Jul; 23(7):877-82. PubMed ID: 18437686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WWOX in biological control and tumorigenesis.
    Aqeilan RI; Croce CM
    J Cell Physiol; 2007 Aug; 212(2):307-10. PubMed ID: 17458891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WWOX, the FRA16D gene, behaves as a suppressor of tumor growth.
    Bednarek AK; Keck-Waggoner CL; Daniel RL; Laflin KJ; Bergsagel PL; Kiguchi K; Brenner AJ; Aldaz CM
    Cancer Res; 2001 Nov; 61(22):8068-73. PubMed ID: 11719429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3.
    Gourley C; Paige AJ; Taylor KJ; Ward C; Kuske B; Zhang J; Sun M; Janczar S; Harrison DJ; Muir M; Smyth JF; Gabra H
    Cancer Res; 2009 Jun; 69(11):4835-42. PubMed ID: 19458077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditional inactivation of the mouse Wwox tumor suppressor gene recapitulates the null phenotype.
    Abdeen SK; Del Mare S; Hussain S; Abu-Remaileh M; Salah Z; Hagan J; Rawahneh M; Pu XA; Russell S; Stein JL; Stein GS; Lian JB; Aqeilan RI
    J Cell Physiol; 2013 Jul; 228(7):1377-82. PubMed ID: 23254685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and characterization of mice carrying a conditional allele of the Wwox tumor suppressor gene.
    Ludes-Meyers JH; Kil H; Parker-Thornburg J; Kusewitt DF; Bedford MT; Aldaz CM
    PLoS One; 2009 Nov; 4(11):e7775. PubMed ID: 19936220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome.
    Nunez MI; Rosen DG; Ludes-Meyers JH; Abba MC; Kil H; Page R; Klein-Szanto AJ; Godwin AK; Liu J; Mills GB; Aldaz CM
    BMC Cancer; 2005 Jun; 5():64. PubMed ID: 15982416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WW domain-containing oxidoreductase's role in myriad cancers: clinical significance and future implications.
    Gardenswartz A; Aqeilan RI
    Exp Biol Med (Maywood); 2014 Mar; 239(3):253-63. PubMed ID: 24510053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma.
    Park SW; Ludes-Meyers J; Zimonjic DB; Durkin ME; Popescu NC; Aldaz CM
    Br J Cancer; 2004 Aug; 91(4):753-9. PubMed ID: 15266310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WWOX, a chromosomal fragile site gene and its role in cancer.
    Ramos D; Aldaz CM
    Adv Exp Med Biol; 2006; 587():149-59. PubMed ID: 17163164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WWOX, the tumour suppressor gene affected in multiple cancers.
    Lewandowska U; Zelazowski M; Seta K; Byczewska M; Pluciennik E; Bednarek AK
    J Physiol Pharmacol; 2009 May; 60 Suppl 1():47-56. PubMed ID: 19609013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of the Wwox gene accelerates forestomach tumor progression in vivo.
    Aqeilan RI; Hagan JP; Aqeilan HA; Pichiorri F; Fong LY; Croce CM
    Cancer Res; 2007 Jun; 67(12):5606-10. PubMed ID: 17575124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ectopic WWOX Expression Inhibits Growth of 5637 Bladder Cancer Cell In Vitro and In Vivo.
    Li G; Sun L; Mu Z; Huang Y; Fu C; Hu B
    Cell Biochem Biophys; 2015 Nov; 73(2):417-425. PubMed ID: 27352332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.
    Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y
    Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WWOX, the chromosomal fragile site FRA16D spanning gene: its role in metabolism and contribution to cancer.
    Richards RI; Choo A; Lee CS; Dayan S; O'Keefe L
    Exp Biol Med (Maywood); 2015 Mar; 240(3):338-44. PubMed ID: 25595186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted ablation of the WW domain-containing oxidoreductase tumor suppressor leads to impaired steroidogenesis.
    Aqeilan RI; Hagan JP; de Bruin A; Rawahneh M; Salah Z; Gaudio E; Siddiqui H; Volinia S; Alder H; Lian JB; Stein GS; Croce CM
    Endocrinology; 2009 Mar; 150(3):1530-5. PubMed ID: 18974271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WWOX, large common fragile site genes, and cancer.
    Gao G; Smith DI
    Exp Biol Med (Maywood); 2015 Mar; 240(3):285-95. PubMed ID: 25595185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.